The stock of Clearmind Medicine Inc (NASDAQ: CMND) has increased by 7.25 when compared to last closing price of 0.97.Despite this, the company has seen a gain of 11.41% in its stock price over the last five trading days. globenewswire.com reported 2025-04-17 that Vancouver, Canada, April 17, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that the United States Patent Office has issued a Notice of Allowance for a patent relating to its MEAI treatment for binge behavior.
Is It Worth Investing in Clearmind Medicine Inc (NASDAQ: CMND) Right Now?
The 36-month beta value for CMND is at -1.31.
The public float for CMND is 2.98M, and currently, shorts hold a 6.19% of that float. The average trading volume for CMND on April 17, 2025 was 67.43K shares.
CMND’s Market Performance
CMND’s stock has seen a 11.41% increase for the week, with a -10.33% drop in the past month and a -31.56% fall in the past quarter. The volatility ratio for the week is 8.31%, and the volatility levels for the past 30 days are at 7.07% for Clearmind Medicine Inc The simple moving average for the past 20 days is 2.51% for CMND’s stock, with a -22.65% simple moving average for the past 200 days.
CMND Trading at -9.46% from the 50-Day Moving Average
After a stumble in the market that brought CMND to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.77% of loss for the given period.
Volatility was left at 7.07%, however, over the last 30 days, the volatility rate increased by 8.31%, as shares sank -8.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.18% lower at present.
During the last 5 trading sessions, CMND rose by +14.60%, which changed the moving average for the period of 200-days by -35.54% in comparison to the 20-day moving average, which settled at $1.0164. In addition, Clearmind Medicine Inc saw -24.62% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CMND
The total capital return value is set at -1.66. Equity return is now at value -125.61, with -59.45 for asset returns.
Based on Clearmind Medicine Inc (CMND), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -101.54. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -106.05.
Currently, EBITDA for the company is -5.85 million with net debt to EBITDA at 1.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.72.
Conclusion
In conclusion, Clearmind Medicine Inc (CMND) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
